Elevated levels of GSTP1 are shown in pancreatic [59] and triple-negative breast cancer cells [12], where it interferes with the cellular signaling processes that influence cell survival, proliferation, and apoptosis. Here, GSTP1 is linked to triple-negative breast carcinoma.